Singapore, Sept. 28 -- United Immunity, a clinical stage biotechnology company, has raised a total of Euro2.2 billion in private financing, comprising Euro1.8 billion through a third-party allotment o... Read More
Singapore, Sept. 28 -- Neuraxpharm Group and Minoryx Therapeutics have announced that the European Commission has granted marketing authorisation under exceptional circumstances for NEZGLYAL(R) (lerig... Read More
Singapore, Sept. 28 -- Deep Origin and partners in the Pharmacological Research and Evaluation through Digital Integration and Clinical Trials Simulation (PREDICTS) consortium announced that their new... Read More
Singapore, Sept. 28 -- As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they are also at the center of the global fight against lung c... Read More
Singapore, Sept. 28 -- Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences, healthcare and biocontainment, has announced the appoint... Read More
Singapore, Sept. 25 -- Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, has reached agreement with a wholly owned subsidiary of leading Australia... Read More
Singapore, Sept. 25 -- QIAGEN N.V. has announced the launch of QIAmini, a compact automated sample preparation system designed to give research laboratories a time-saving and cost-efficient alternativ... Read More
Singapore, Sept. 25 -- Cellares, US-based Integrated Development and Manufacturing Organisation (IDMO), and Seoul National University Hospital (SNUH), a leading translational medical centre in South K... Read More
Singapore, Sept. 24 -- The University of Melbourne has joined the Structural Genomics Consortium (SGC) with the establishment of SGC-Melbourne, a new SGC Affiliated Site and the consortium's only site... Read More
Singapore, Sept. 24 -- Novo Nordisk has announced that Singapore's Health Sciences Authority (HSA) has approved Wegovy(R) (once-weekly injectable semaglutide 2.4 mg) as the first approved treatment in... Read More